Table 2 Prevalence of beta-HPV species and frequency of multiple infections in tumour and in perilesional skin samples from NMSC immunocompetent patients
Diagnosis | Tumour biopsy | Perilesional biopsy | Total |
|---|---|---|---|
| Â | No. of positive/total (%) | No. of positive/total (%) | No. of positive/total (%) |
| Â | Â | Beta1-HPV | Â |
BCC | 29/50 (56) | 19/50 (38) | 48/100 (48) |
SCC | 7/9 (76) | 5/9 (56) | 12/18 (67) |
Total | 36/59 (61) | 24/59 (41) | 60/118 (51) |
| Â | Â | Other than beta1-HPV | Â |
BCC | 18/50 (36) | 15/50 (30) | 33/100 (33) |
SCC | 5/9 (56) | 2/9 (22) | 7/18 (39) |
Total | 23/59 (39) | 17/59 (29) | 40/118 (34) |
| Â | Â | Multiple infection | Â |
BCC | 22/50 (44) | 12/50 (24) | 34/100 (34) |
SCC | 6/9 (67) | 4/9 (22) | 10/18 (56) |
Total | 28/59 (47) | 16/59 (27) | 44/118 (37) |